Rigel Pharmaceuticals (RIGL): Soleus Capital group discloses 9.9% ownership stake
Soleus Capital Master Fund, L.P. and its affiliated entities have reported a 9.9% beneficial ownership stake in Rigel Pharmaceuticals, Inc. (RIGL). This ownership amounts to 1,843,504 shares of common stock, based on 18,679,864 shares outstanding as of July 30, 2026. The filing indicates shared …